000 | 01953 a2200601 4500 | ||
---|---|---|---|
005 | 20250513224018.0 | ||
264 | 0 | _c20001228 | |
008 | 200012s 0 0 eng d | ||
022 | _a1524-4539 | ||
024 | 7 |
_a10.1161/01.cir.102.suppl_3.iii-222 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCaforio, A L | |
245 | 0 | 0 |
_aSkin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. _h[electronic resource] |
260 |
_bCirculation _cNov 2000 |
||
300 |
_aIII222-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAge Distribution |
650 | 0 | 4 |
_aAzathioprine _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeart Transplantation _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKeratosis _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
650 | 0 | 4 | _aSkin Pigmentation |
650 | 0 | 4 |
_aSunlight _xadverse effects |
700 | 1 | _aFortina, A B | |
700 | 1 | _aPiaserico, S | |
700 | 1 | _aAlaibac, M | |
700 | 1 | _aTona, F | |
700 | 1 | _aFeltrin, G | |
700 | 1 | _aPompei, E | |
700 | 1 | _aTestolin, L | |
700 | 1 | _aGambino, A | |
700 | 1 | _aVolta, S D | |
700 | 1 | _aThiene, G | |
700 | 1 | _aCasarotto, D | |
700 | 1 | _aPeserico, A | |
773 | 0 |
_tCirculation _gvol. 102 _gno. 19 Suppl 3 _gp. III222-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.102.suppl_3.iii-222 _zAvailable from publisher's website |
999 |
_c11024048 _d11024048 |